All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2011-004074-28 | A prospective, open label, multicenter, partially randomized, safety study of one cycle of Promethera HepaStem in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients Uno studio sperimentale p... | 2014-11-04 | due-trials |
| Reported results | 2013-001045-14 | SAF 001: A long-term safety follow-up study of patients having received infusions of HepaStem. | 2017-07-20 | due-trials |
| Reported results | 2014-000650-11 | A prospective, open label, multi-country, multicenter, efficacy and safety study of several infusions of Promethera HepaStem in Urea Cycle Disorders pediatric patients HEP002: Estudio prospectivo, ... | 2019-08-01 | due-trials |
| Trial is outside EEC, and reported results | 2015-000988-14 | Title: Open, Prospective, Historic-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Infusion of Liver Cell Suspension (HHLivC) in Children with Urea Cycle Disorders | bad-data | |
| Reported results | 2016-001177-32 | Multicenter Phase II Safety and Preliminary Efficacy Study of 2 dose regimens of HepaStem in Patients with Acute on Chronic Liver Failure | 2020-08-21 | due-trials |
| Other | 2017-003989-27 | HepaStem Long-Term Safety Registry : Registry for patients who have been administered HepaStem | not-yet-due | |
| Listed as ongoing, but also has a completion date and reported results | 2018-004449-18 | Multicenter, open-label, safety and tolerability study of ascending doses of HepaStem in patients with cirrhotic and pre-cirrhotic non-alcoholic steato-hepatitis (NASH). | 2020-08-31 | bad-data |
| Ongoing | 2019-003051-11 | Randomized, placebo-controlled, double blind, multi-centre Phase IIb study to evaluate the efficacy and safety of HepaStem in patients with Acute on Chronic Liver Failure (ACLF) - DHELIVER Stud... | not-yet-due |